DD202532A5 - Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols - Google Patents

Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols Download PDF

Info

Publication number
DD202532A5
DD202532A5 DD81242603A DD24260381A DD202532A5 DD 202532 A5 DD202532 A5 DD 202532A5 DD 81242603 A DD81242603 A DD 81242603A DD 24260381 A DD24260381 A DD 24260381A DD 202532 A5 DD202532 A5 DD 202532A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
amino
phenoxy
compounds
preparation
Prior art date
Application number
DD81242603A
Other languages
German (de)
English (en)
Inventor
Franz Ostermayer
Markus Zimmermann
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of DD202532A5 publication Critical patent/DD202532A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/201,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD81242603A 1980-08-13 1981-08-11 Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols DD202532A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH611880 1980-08-13

Publications (1)

Publication Number Publication Date
DD202532A5 true DD202532A5 (de) 1983-09-21

Family

ID=4304561

Family Applications (3)

Application Number Title Priority Date Filing Date
DD81232528A DD202286A5 (de) 1980-08-13 1981-08-11 Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
DD81242604A DD202691A5 (de) 1980-08-13 1981-08-11 Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
DD81242603A DD202532A5 (de) 1980-08-13 1981-08-11 Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DD81232528A DD202286A5 (de) 1980-08-13 1981-08-11 Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
DD81242604A DD202691A5 (de) 1980-08-13 1981-08-11 Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols

Country Status (17)

Country Link
EP (1) EP0045964A1 (enrdf_load_html_response)
JP (1) JPS5759842A (enrdf_load_html_response)
KR (1) KR840002266B1 (enrdf_load_html_response)
AR (6) AR231273A1 (enrdf_load_html_response)
AU (1) AU543647B2 (enrdf_load_html_response)
CA (1) CA1192221A (enrdf_load_html_response)
DD (3) DD202286A5 (enrdf_load_html_response)
DK (1) DK358381A (enrdf_load_html_response)
ES (8) ES504682A0 (enrdf_load_html_response)
FI (1) FI812465A7 (enrdf_load_html_response)
GR (1) GR74992B (enrdf_load_html_response)
HU (1) HU186342B (enrdf_load_html_response)
IL (1) IL63539A (enrdf_load_html_response)
NO (1) NO812736L (enrdf_load_html_response)
NZ (1) NZ198020A (enrdf_load_html_response)
PT (1) PT73511B (enrdf_load_html_response)
ZA (1) ZA815554B (enrdf_load_html_response)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58417B1 (en) * 1984-04-27 1993-09-22 Ici Plc Chemical derivatives
GB201101959D0 (en) * 2011-02-04 2011-03-23 Univ Nottingham Novel ether linked compoundsand improved treatments for cardiac and cardiovascular disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1398738A (en) * 1972-12-05 1975-06-25 Pfizer Ltd Propanolamine derivatives
FI791727A7 (fi) * 1978-06-05 1981-01-01 Ciba Geigy Ag Menetelmä N-alkyloitujen aminoalkoholien valmistamiseksi.
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols

Also Published As

Publication number Publication date
HU186342B (en) 1985-07-29
PT73511A (en) 1981-09-01
ES8301462A1 (es) 1982-12-01
AR231274A1 (es) 1984-10-31
ES8305694A1 (es) 1983-05-01
CA1192221A (en) 1985-08-20
ES514367A0 (es) 1983-04-16
AR231631A1 (es) 1985-01-31
AR231275A1 (es) 1984-10-31
ES8305689A1 (es) 1983-04-16
KR830006173A (ko) 1983-09-17
ES514371A0 (es) 1983-05-01
ES8305693A1 (es) 1983-05-01
ES504682A0 (es) 1982-12-01
KR840002266B1 (ko) 1984-12-14
ES514365A0 (es) 1983-04-16
AU543647B2 (en) 1985-04-26
DD202286A5 (de) 1983-09-07
ES8305691A1 (es) 1983-04-16
FI812465L (fi) 1982-02-14
DK358381A (da) 1982-02-14
NO812736L (no) 1982-02-15
AR229188A1 (es) 1983-06-30
IL63539A0 (en) 1981-11-30
FI812465A7 (fi) 1982-02-14
NZ198020A (en) 1985-04-30
PT73511B (en) 1983-07-06
AU7402081A (en) 1982-02-18
GR74992B (enrdf_load_html_response) 1984-07-12
ES514368A0 (es) 1983-05-01
AR231278A1 (es) 1984-10-31
IL63539A (en) 1984-11-30
ES8305690A1 (es) 1983-05-01
ES8306473A1 (es) 1983-06-01
EP0045964A1 (de) 1982-02-17
JPS5759842A (en) 1982-04-10
ES514369A0 (es) 1983-05-01
ZA815554B (en) 1982-08-25
ES514370A0 (es) 1983-06-01
ES8305692A1 (es) 1983-05-01
DD202691A5 (de) 1983-09-28
ES514366A0 (es) 1983-05-01
AR231273A1 (es) 1984-10-31

Similar Documents

Publication Publication Date Title
EP0005848B1 (de) N-Alkylierte Aminoalkohole und ihre Salze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
EP0015505B1 (de) Derivate des 3-Amino-1,2-propandiols, Verfahren zu ihrer Herstellung und pharmazeutische Präparate enthaltend solche Verbindungen und Verwendung von letzteren
DE1443599A1 (de) Ungesaettigte Amine
DE2531312A1 (de) Aminderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
EP0065295A1 (de) Substituierte Tryptaminderivate von Thienyloxypropanolaminen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen sowie ihre Verwendung
DD144665A5 (de) Verfahren zur herstellung von 1-phenoxy-3-aminopropan-2-olen
DE2723051B2 (de) N^AcyO-p-amino-N'-Oi-decyl- und n-tridecyO-benzamide sowie diese enthaltende Arzneimittel
DE2653147C2 (enrdf_load_html_response)
CH641162A5 (de) Verfahren zur herstellung neuer phenylazacycloalkane.
DD202532A5 (de) Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
DD202692A5 (de) Verfahren zur herstellung neuer derivate des 2-amino-aethanols
DE2062055C3 (de) Propanolamin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2137538C3 (de) oxyamin und seine Salze sowie ein Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
DD144764A5 (de) Verfahren zur herstellung von r-n-(2-phenyl-2-hydroxyethyl)-3-phenylpropylaminen
DE3407654A1 (de) Benzamid-derivate
DE2743493A1 (de) Amine, verfahren zu deren herstellung und sie enthaltende arzneimittel
EP0124479B1 (de) Iminosulfonamide und Verfahren zu ihrer Herstellung, die pharmazeutische Präparate solche Verbindungen enthalten, sowie die Verbindungen zur Verwendung
DE69507113T2 (de) Therapeutisches Mittel zur Behandlung von ischämischen oder Reperfusion Schädigungen des Myokards
AT360018B (de) Verfahren zur herstellung des neuen 4-(7-brom-5 -methoxy-2-benzofuranyl)- piperidins und seiner saeureadditionssalze
DD141926A6 (de) Verfahren zur herstellung von neuen veraetherten hydroxybenzodiheterocyclen
AT334342B (de) Verfahren zur herstellung von neuen alpha- (1-bis-arylalkylaminoalkyl) -aralkoxybenzylalkoholen
AT334338B (de) Verfahren zur herstellung von neuen alpha- (1-bis-arylalkylaminoalkyl) -aralkoxybenzylalkoholen
AT304506B (de) Verfahren zur Herstellung neuer Anthracenverbindungen
DE2421549A1 (de) Naphthalinderivate, verfahren zu ihrer herstellung und arzneimittel
AT371101B (de) Verfahren zur herstellung neuer optisch aktiver phenethanolamine und der pharmazeutisch unbedenklichen salze hiervon